With COVID-19 further validating the necessity and utility of virtual care, emocha CEO Sebastian Seiguer predicts that 2021 will be full of mergers and acquisitions for companies that differentiate themselves in digital health technology. Funding for such ventures is largely a nonissue, as digital health solutions have become part of our everyday experience; investors are keenly aware that consumers have grown more accustomed to digital health. The question remains: which companies will succeed in ensuring that their products and services are not only popular, but also clinically validated? It is insufficient to solely promote wellness, and COVID-19 will likely require an evolution of the currently available technologies to serve a yet unresearched population — COVID-19 survivors. Those companies that can adapt and evolve at the speed required will be the leaders in the next wave of digital health innovation and tech.

Read the full article in NASDAQ